Beyfortus 100 MG/ML syringeml
Ended Awarded
- Contract number
- SPE2DB25FVKLY
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $333,058
Award facts
- Contract value 100% obligated
- $333,058.26 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $333,058.26 to AmerisourceBergen Drug Corp for the supply of Beyfortus (respiratory syncytial virus monoclonal antibody) 100 mg/ml syringes. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 3, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.9 billion global pharmaceutical support vehicle running through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement across the Defense Health Agency and other government healthcare systems. The company's extensive portfolio of federal contracts demonstrates its capability to fulfill diverse pharmaceutical needs, ranging from brand-name and generic medications to specialized medical supplies, all awarded through competitive procurement processes. This delivery order for Beyfortus, a preventive monoclonal antibody used to protect infants against respiratory syncytial virus, reflects the company's role in supporting military and federal healthcare medical supply chains with specialized pharmaceutical products.
Quick answers
Who was awarded contract SPE2DB25FVKLY?
SPE2DB25FVKLY was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 2, 2025.
How much is contract SPE2DB25FVKLY worth?
The government has obligated $333,058 on SPE2DB25FVKLY.
Is contract SPE2DB25FVKLY an order under another contract?
Yes. SPE2DB25FVKLY is a delivery order under SPE2DB25D3017, an indefinite delivery contract.
Was contract SPE2DB25FVKLY competed?
The extent of competition for SPE2DB25FVKLY was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award